Table 2 Endocrine treatments details (n = 13)
1st line (n = 13) | N (%) median (range) |
|---|---|
Median age at 1st line hormonal treatment | 49 years (39–70) |
Type of 1 st line hormonal treatment | |
NSAI | 11 (84.6%) |
Progestins | 2 (15.4%) |
Response to 1 st line | |
Complete response | 0 (0%) |
Partial response | 6 (46.2%) |
Stable disease (more than 6 months) | 6(46.2%) |
Progressive disease | 1(7.6%) |
2nd line (n = 10) | |
Median age at 2nd line hormonal treatment | 59 years (43–72) |
Type of 2 nd line hormonal treatment | |
NSAI | 4 (40%) |
Exemestane | 3 (30%) |
Progestins | 2 (20%) |
GnRH analogue | 1 (10%) |
Response to 2 nd line | |
Complete response | 0 (0%) |
Partial response | 0 (0%) |
Stable disease (more than 6 months) | 10(100%) |
Progressive disease | 0 (0%) |